Source: The Korea Bizwire

TEVA: Teva Releases Q1 2025 Aide Memoire

TEL AVIV, Israel, March 27, 2025 (Korea Bizwire) - Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that its Q1 2025 Aide Memoire is available on the "Investors" page on its website. Q1 2025 Aide Memoire Teva has prepared this document to assist in the financial modeling of its quarterly results. The document [...]The post Teva Releases Q1 2025 Aide Memoire appeared first on Be Korea-savvy.

Read full article »
TEVA's Competitors | TEVA's News | TEVA's Financials
Stay up-to-date with the latest news on TEVA
Annual Revenue
$10-50B
Employees
10-50K
Richard Francis's photo - President & CEO of TEVA

President & CEO

Richard Francis

CEO Approval Rating

82/100

Read more
Stay up-to-date with the latest news on TEVA